Driving Performance and Cannabis Users' Perception of Safety: A Randomized Clinical Trial [0.03%]
驾驶性能与大麻使用者的安全感知：随机临床试验
Thomas D Marcotte,Anya Umlauf,David J Grelotti et al.
Thomas D Marcotte et al.
Importance: Expanding cannabis medicalization and legalization increases the urgency to understand the factors associated with acute driving impairment. O...
Randomized Controlled Trial
JAMA psychiatry. 2022 Mar 1;79(3):201-209. DOI:10.1001/jamapsychiatry.2021.4037 2022
Joshua Phelps,Ravi N Shah,Jeffrey A Lieberman
Joshua Phelps
Dissimilar Control Interventions in Clinical Trials Undermine Interpretability-Reply [0.03%]
临床试验中的不同控制干预措施损害了可解释性——回复文章
Yoni K Ashar,Tor D Wager
Yoni K Ashar
Dissimilar Control Interventions in Clinical Trials Undermine Interpretability [0.03%]
临床试验中的不同控制干预措施损害了可解释性
David Hohenschurz-Schmidt,Jerry Draper-Rodi,Lene Vase
David Hohenschurz-Schmidt
National Trends of Mental Health Care Among US Adults Who Attempted Suicide in the Past 12 Months [0.03%]
过去一年内美国成人自杀未遂者的心理健康状况国家趋势分析报告
Tanner J Bommersbach,Robert A Rosenheck,Taeho Greg Rhee
Tanner J Bommersbach
Importance: Although suicide attempts remain the strongest risk factor for future suicide, little is known about recent trends in the prevalence of and risk factors for suicide attempts and past-year use of services among...
Error in Discussion Section [0.03%]
讨论部分的错误
Published Erratum
JAMA psychiatry. 2022 Mar 1;79(3):272. DOI:10.1001/jamapsychiatry.2021.4110 2022
Methadone on Wheels-A New Option to Expand Access to Care Through Mobile Units [0.03%]
流动的美沙酮-通过流动服务单元扩大治疗范围的新选择
Jason B Gibbons,Elizabeth A Stuart,Brendan Saloner
Jason B Gibbons
Rie Toyomoto,Satoshi Funada,Toshi A Furukawa
Rie Toyomoto
Ryan J Van Lieshout,Calan Savoy,Steven Hanna
Ryan J Van Lieshout
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia [0.03%]
用于估计常见遗传变异与精神分裂症治疗抵抗关联的交互作用检验和多基因风险评分研究
Antonio F Pardiñas,Sophie E Smart,Isabella R Willcocks et al.
Antonio F Pardiñas et al.
Importance: About 20% to 30% of people with schizophrenia have psychotic symptoms that do not respond adequately to first-line antipsychotic treatment. This clinical presentation, chronic and highly disabling, is known as...